We have expanded not only to a more clinically relevant HK formulation but also to additional models of vaccine strategies to protect against cryptococcosis during CD4-deficiency, including using our vaccine as a therapeutic mean and using our vaccine to prevent reactivation of a latent infection upon immunodepression. Here, CD4 is linked to cryptococcosis.